Characterizing neuropathies associated with monoclonal gammopathy of undertermined significance (MGUS): A framework consistent with classifying injuries according to fiber size

Neurology and Clinical Neurophysiology

Volumn 2002, Issue , 2002, Pages

  Fisher, Morris A ^a,b   Wilson, John R ^a,b  

^a HINES VA HOSPITAL   (United States)

^b LOYOLA UNIVERSITY CHICAGO   (United States)

Author keywords

Fiber size; Immunologic; Monoclonal gammopathy of undertermined significance (MGUS); Neuropathy; Quantitative sensory testing (QST)

Indexed keywords

IMMUNOGLOBULIN A; IMMUNOGLOBULIN CLASS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M;

AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL EXAMINATION; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; FREQUENCY ANALYSIS; GERIATRICS; HUMAN; HUMAN TISSUE; IMMUNOLOGY; MONOCLONAL IMMUNOGLOBULINEMIA; NEUROPATHY; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUANTITATIVE ANALYSIS; SENSORY ANALYSIS; BIOPSY; BLOOD; CLASSIFICATION; CLINICAL TRIAL; DIFFERENTIAL DIAGNOSIS; ELECTRODIAGNOSIS; MIDDLE AGED; MOTONEURON; NERVE FIBER; NEUROLOGIC EXAMINATION; PARAPROTEINEMIA; PATHOLOGY; POLYNEUROPATHY; SENSORY NERVE CELL; STIMULATION; SURAL NERVE; VIBRATION;

AGED; AGED, 80 AND OVER; BIOPSY; DIAGNOSIS, DIFFERENTIAL; ELECTRODIAGNOSIS; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MIDDLE AGED; MOTOR NEURONS; NERVE FIBERS; NEUROLOGIC EXAMINATION; NEURONS, AFFERENT; PARAPROTEINEMIAS; PHYSICAL STIMULATION; POLYNEUROPATHIES; PROSPECTIVE STUDIES; SURAL NERVE; VIBRATION;

EID: 0036368872     PISSN: 15268748     EISSN: 15268748     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Blume G, Pestronk A, Goodnough LT. Anti-MAG antibody associated polyneuropathies: improvement following immunotherapy with monthly plasma exchange and IV cyclophosphamide. Neurology. 1995;45:1577-1580.
2. Fisher MA, Wilson JR. Asymmetric electrodiagnosis: findings in monoclonal gammopathy of uncertain significance. Muscle Nerve. 1999;22:1331.
3. Hays AR, Latov N, Takatsu M, Sherman WH. Experimental demyelination of nerve induced by serum of patients with neuropathy and an anti-MAG IgM M-protein. Neurology. 1987;37:242-250.
4. Kaku DA, England JD, Sumner AJ. Distal accentuation of conduction slowing in polyneuropathy associated with antibodies to myelin associated glycoprotein and sulfated glucuronylparagloboside. Brain. 1994;117:941-947.
5. Kyle RA, Dyck PJ. Neuropathies associated with monoclonal gammopathies In: Dyck PJ, Thomas PK, Griffin JW, et al, eds. Peripheral Neuropathy. Philadelphia, PA: Saunders; 1993:1275-1287
6. Latov N. Pathogenesis and therapy of neuropathies associated with monoclonal gammopathies. Ann Neurol. 1995;37:532-542.
7. Latov N, Sherman WH, Vlahides G. Therapy of neuropathy associated with anti-MAG IgM monoclonal gammopathy with Rituxan. Neurology 1999;52(suppl 2):A551.
8. Nobile-Orazio E, Barbieri S, Baldini L, et al. Peripheral neuropathy in monoclonal gammopathy of undetermined significance: prevalence and immunopathogenetics studies Acta Neurol Scand., 1992;85:383-390.
9. Osby E, Noring L, Hast T, et al. Benign monoclonal gammopathy and peripheral neuropathy. Br J Haematol. 1982;51:531-539.
10. Quarles RH, Weiss MD. Autoantibodies associated with peripheral neuropathy. Muscle Nerve. 1999;22:800-822.
11. Radl J, Spers JM, Skuaril F, et al. Immunoglobulin patterns in humans over 95 years of age. Clin Exp Immunol. 1975;22:84-90.
12. Ritz M-F, Erne B, Ferranin F, et al. Anti-MAG IgM penetration into myelinated fibers correlates with the extent of myelin widening. Muscle Nerve. 1999;22:1030-1037.
13. Ropper AH, Gorson KC. Neuropathies associated with paraproteinemia N Engl J Med. 1998;338:1601-1607.
14. Suarez GA, Dyck PJ. Quantitative sensory testing. In: Dyck PJ, Thomas PH, ed. Diabetic Neuropathy. Philadelphia, PA: Saunders; 1999:151-169.
15. Suarez GA, Kelly JJ Jr. Polyneuropathy asociated with monoclonal gammopathy of undetermined significance. Neurology. 1993;43:1304-1308.
16. Tatum AH. Experimental paraprotein neuropathy: demyelination by passive transfer of human IgG anti-myelin associated glycoprotein. Ann Neurol. 1993;33:502-506.
17. Trojaborg W, Galassi G, Hays AP, et al. Electrophysiologic study of experimental demyelination induced by serum of patients with IgM M proteins and neuropathy. Neurology. 1989;39:1581-1586.
18. Vrethem M, Cruz M, We-In H, et al. Clinical neurophysiological and immunological evidence of polyneuropathy in patients with monoclonal gammopathies J Neurol Sci. 1993;113:193-199.
19. Willison HJ, Trapp BD, Bacher JD, et al. Demyelination induced by intraneural injection of human antimyelin associated glycoprotein antibodies. Muscle Nerve. 1988;11:1169-1176.
20. Wilson JR, Stittsworth JD Jr, Fisher MA. Electrodiagnostic patterns in MGUS neuropathy. Electromyogr Clin Neurophysiol. 2001;41:409-418.